ReviewPharmaceutical patent analyst2024

Proteolysis targeting chimeras (PROTACs) in oncology: a review of patents and regulatory considerations.

Sowndharya M et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.